Pharmadrug Stock Performance

LMLLF Stock  USD 0.01  0  29.73%   
On a scale of 0 to 100, Pharmadrug holds a performance score of 2. The company holds a Beta of 2.05, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharmadrug will likely underperform. Please check Pharmadrug's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Pharmadrug's historical price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Pharmadrug Relative Risk vs. Return Landscape

If you would invest  1.73  in Pharmadrug on November 7, 2025 and sell it today you would lose (0.77) from holding Pharmadrug or give up 44.51% of portfolio value over 90 days. Pharmadrug is currently producing 0.5465% returns and takes up 17.2783% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Pharmadrug, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Pharmadrug is expected to generate 22.94 times more return on investment than the market. However, the company is 22.94 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Pharmadrug Target Price Odds to finish over Current Price

The tendency of Pharmadrug Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 85.06
Based on a normal probability distribution, the odds of Pharmadrug to move above the current price in 90 days from now is about 85.06 (This Pharmadrug probability density function shows the probability of Pharmadrug Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 2.05 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pharmadrug will likely underperform. Moreover Pharmadrug has an alpha of 1.4293, implying that it can generate a 1.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Pharmadrug Price Density   
       Price  

Predictive Modules for Pharmadrug

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmadrug. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0117.57
Details
Intrinsic
Valuation
LowRealHigh
0.000.0117.57
Details
Naive
Forecast
LowNextHigh
0.00020.0117.57
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details

Pharmadrug Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmadrug is not an exception. The market had few large corrections towards the Pharmadrug's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmadrug, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmadrug within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.43
β
Beta against Dow Jones2.05
σ
Overall volatility
0
Ir
Information ratio 0.09

Pharmadrug Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmadrug for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmadrug can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pharmadrug is way too risky over 90 days horizon
Pharmadrug has some characteristics of a very speculative penny stock
Pharmadrug appears to be risky and price may revert if volatility continues
The company reported the revenue of 494.99 K. Net Loss for the year was (5.63 M) with profit before overhead, payroll, taxes, and interest of 182.04 K.
Pharmadrug has accumulated about 126.38 K in cash with (4.13 M) of positive cash flow from operations.

Pharmadrug Fundamentals Growth

Pharmadrug Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Pharmadrug, and Pharmadrug fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmadrug Pink Sheet performance.

About Pharmadrug Performance

By analyzing Pharmadrug's fundamental ratios, stakeholders can gain valuable insights into Pharmadrug's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmadrug has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmadrug has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Things to note about Pharmadrug performance evaluation

Checking the ongoing alerts about Pharmadrug for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Pharmadrug help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharmadrug is way too risky over 90 days horizon
Pharmadrug has some characteristics of a very speculative penny stock
Pharmadrug appears to be risky and price may revert if volatility continues
The company reported the revenue of 494.99 K. Net Loss for the year was (5.63 M) with profit before overhead, payroll, taxes, and interest of 182.04 K.
Pharmadrug has accumulated about 126.38 K in cash with (4.13 M) of positive cash flow from operations.
Evaluating Pharmadrug's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Pharmadrug's pink sheet performance include:
  • Analyzing Pharmadrug's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmadrug's stock is overvalued or undervalued compared to its peers.
  • Examining Pharmadrug's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Pharmadrug's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmadrug's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Pharmadrug's pink sheet. These opinions can provide insight into Pharmadrug's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Pharmadrug's pink sheet performance is not an exact science, and many factors can impact Pharmadrug's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Pharmadrug Pink Sheet analysis

When running Pharmadrug's price analysis, check to measure Pharmadrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmadrug is operating at the current time. Most of Pharmadrug's value examination focuses on studying past and present price action to predict the probability of Pharmadrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmadrug's price. Additionally, you may evaluate how the addition of Pharmadrug to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes